Lisata Therapeutics to Report Second Quarter 2023 Financial Results on Monday August 14 After Market Trading and to Host Conference Call on Tuesday August 15 at 830 am Eastern Time

BASKING RIDGE, N.J., Aug. 07, 2023 (GLOBE NEWSWIRE) — Lisata Therapeutics, Inc. (Nasdaq: LSTA) (“Lisata” or the “Company”), a clinical-stage pharmaceutical company developing innovative therapies for the treatment of advanced solid tumors and other serious diseases, announced today that it will report its financial results for the second quarter ended…Read More